Renal phosphate wasting disorders: Clinical features and pathogenesis

被引:43
|
作者
Brame, LA
White, KE
Econs, MJ
机构
[1] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA
[2] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN USA
关键词
D O I
10.1053/j.semnephrol.2003.08.016
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Rickets and osteomalacia are associated with hypophosphatemia in several disease states, including X-linked hypophosphatemic rickets, autosomal-dominant hypophosphatemic rickets, and tumor-induced osteomalacia. Recent advances in the understanding of these diseases include discovery of mutations in the genes encoding human phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX) and fibroblast growth factor 23 (FGF-23) and the finding of overproduction of FGF-23 and other proteins including matrix extracellular phosphoglycoprotein (MEPE) and frizzled-related protein 4 (FRP-4) in tumor-induced osteomalacia. Research is ongoing to better define how these proteins relate to each other and to the sodium-phosphate cotransporter in both normal and abnormal phosphate metabolism. New and improved therapies for disorders of phosphate metabolism, osteomalacia, and rickets will develop as our knowledge of phosphate metabolism grows. © 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 50 条
  • [21] Renal Phosphate Wasting in the Absence of Adenylyl Cyclase 6
    Fenton, Robert A.
    Murray, Fiona
    Rieg, Jessica A. Dominguez
    Tang, Tong
    Levi, Moshe
    Rieg, Tinno
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (12): : 2822 - 2834
  • [22] REVERSIBLE RENAL PHOSPHATE WASTING SECONDARY TO DESFERASIROX THERAPY
    Milat, F.
    Johnstone, L.
    Kerr, P.
    Doery, J.
    Strauss, B.
    Bowden, D.
    NEPHROLOGY, 2010, 15 : 44 - 44
  • [23] DIVERTICULAR DISORDERS OF COLON .1. PATHOGENESIS, CLINICAL FEATURES, AND DIAGNOSIS
    ELLIS, H
    POSTGRADUATE MEDICINE, 1973, 53 (04) : 149 - 154
  • [25] RENAL PHOSPHATE WASTING IN IDIOPATHIC CALCIUM STONE FORMERS
    SUTTON, RAL
    WALKER, VR
    MINERAL AND ELECTROLYTE METABOLISM, 1981, 6 (4-5) : 266 - 267
  • [26] CLINICAL SPECTRUM OF RENAL POTASSIUM WASTING
    DREW, WL
    YOUKER, JE
    SMITH, LH
    SEBASTIA.A
    EARLEY, LE
    SALMON, SE
    CALIFORNIA MEDICINE, 1969, 110 (06): : 493 - &
  • [27] Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders
    Wang, Rebecca F.
    Ko, Dayoung
    Friedman, Ben J.
    Lim, Henry W.
    Mohammad, Tasneem F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (02) : 271 - 288
  • [28] PROTEIN WASTING IN THE CRITICALLY ILL - PATHOGENESIS AND CLINICAL IMPLICATIONS
    KELLER, U
    INTENSIVE CARE MEDICINE, 1983, 9 (04) : 168 - 168
  • [29] CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders
    Bai, Xiuying
    Miao, Dengshun
    Xiao, Sophia
    Qiu, Dinghong
    St-Arnaud, Rene
    Petkovich, Martin
    Gupta, Ajay
    Goltzman, David
    Karaplis, Andrew C.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (02): : 667 - 680
  • [30] RENAL MAGNESIUM WASTING WITH HYPERCALCIURIA, NEPHROCALCINOSIS AND OCULAR DISORDERS
    TORRALBO, A
    PINA, E
    PORTOLES, J
    SANCHEZFRUCTUOSO, A
    BARRIENTOS, A
    NEPHRON, 1995, 69 (04): : 472 - 475